Form 4: ATAI Life Sciences Director Extends Expiration Dates on Pre-IPO Stock Options

Christian Angermayer, a director and 10% owner of ATAI Life Sciences N.V., extended the expiration dates of certain pre-IPO stock options to align with the company's 2021 Incentive Award Plan.

Summary

• Christian Angermayer, a director and 10% owner of ATAI Life Sciences N.V., reported changes in beneficial ownership on October 4, 2024.
• The reported transactions involve the extension of the expiration date of pre-IPO stock options.
• These extensions align the pre-IPO options with those granted under the Issuer's 2021 Incentive Award Plan.
• Angermayer extended the expiration date on 624,000 stock options with an exercise price of $5.68 from August 20, 2025, to August 20, 2030.
• The stock options are fully vested and currently exercisable.

Sentiment

Score: 7

Explanation: The document reflects a standard administrative action (extending option expiration dates) to align with market practices, suggesting a neutral to slightly positive sentiment as it ensures continued alignment of incentives.

Positives

• The extension of the expiration date of pre-IPO stock options aligns them with the company's 2021 Incentive Award Plan, which is consistent with prevailing market practices.

Management Comments

• The transactions reported herein reflect the extension of the expiration date of certain pre-IPO stock options to align them with options granted under the Issuer's 2021 Incentive Award Plan, which is consistent with prevailing market practices.

Industry Context

Extending the expiration dates of pre-IPO stock options to align with standard incentive plans is a common practice to ensure that employees and directors remain incentivized and aligned with the long-term success of the company. This is especially relevant in the biotech industry, where long development timelines are common.

Comparison to Industry Standards

• Many biotech companies, such as Compass Pathways and Mind Medicine, have similar incentive plans that include stock options with vesting schedules and expiration dates.
• The extension of option expiration dates is a fairly standard practice to retain key personnel, especially in volatile sectors like biotech.
• The specific terms of the ATAI Life Sciences' 2021 Incentive Award Plan would need to be compared to those of its peers to fully assess its competitiveness.

Stakeholder Impact

• The extension of stock option expiration dates could positively impact employees and directors by ensuring their continued alignment with the company's long-term success.
• Shareholders may view this as a positive step as it helps retain key personnel.

Key Dates